The Standard for Diagnosis and Treatment of Gastric Cancer published by China Ministry of Health in 2011 clearly advocates that individualized treatment strategy based on D2 standard radical surgery should be recommended, which is according to staging and biologic typing. The present review will comment on the strategy from the following aspects: clinical TNM staging, pathological TNM staging, biologic typing, occult lymph node metastasis and molecular typing.